Bliss GVS Pharma Limited

Bliss GVS Pharma Limited (BLISSGVS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

blissgvs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹639.35
Market cap
6,772 Cr
Stock P/E
49.1
P/B
5.48
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales212 Cr201 Cr198 Cr184 Cr218 Cr210 Cr198 Cr207 Cr244 Cr218 Cr257 Cr286 Cr
Operating expenses (approx.)158 Cr157 Cr170 Cr149 Cr176 Cr181 Cr177 Cr166 Cr213 Cr183 Cr213 Cr209 Cr
EBITDA54 Cr44 Cr28 Cr34 Cr41 Cr30 Cr21 Cr41 Cr32 Cr35 Cr44 Cr76 Cr
OPM %25.7%21.8%14.3%18.7%19.1%14.2%10.7%19.9%13.0%15.9%17.3%26.8%
Other income13 Cr5 Cr6 Cr4 Cr5 Cr15 Cr12 Cr35 Cr20 Cr18 Cr11 Cr10 Cr
Interest1 Cr2 Cr2 Cr2 Cr4 Cr1 Cr2 Cr5 Cr3 Cr1 Cr2 Cr0.58 Cr
Depreciation6 Cr7 Cr7 Cr7 Cr7 Cr8 Cr8 Cr8 Cr8 Cr8 Cr9 Cr10 Cr
Profit before tax59 Cr40 Cr-4 Cr30 Cr36 Cr36 Cr23 Cr63 Cr41 Cr41 Cr45 Cr75 Cr
Tax %27.2%27.4%-24.4%26.5%28.0%29.1%29.0%29.7%29.6%39.4%17.7%31.9%
Net profit43 Cr29 Cr-5 Cr22 Cr26 Cr26 Cr17 Cr44 Cr29 Cr25 Cr37 Cr51 Cr
EPS (₹)₹4.06₹2.64₹-0.88₹1.97₹2.31₹2.27₹1.47₹4.08₹2.58₹2.20₹3.37₹4.73

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales898 Cr689 Cr577 Cr747 Cr752 Cr770 Cr810 Cr927 CrSign in for TTM
Operating expenses (approx.)741 Cr566 Cr471 Cr629 Cr634 Cr620 Cr683 Cr763 CrSign in for TTM
EBITDA158 Cr123 Cr107 Cr118 Cr117 Cr151 Cr127 Cr164 CrSign in for TTM
OPM %17.5%17.9%18.5%15.8%15.6%19.6%15.6%17.7%Sign in for TTM
Other income38 Cr37 Cr20 Cr31 Cr18 Cr29 Cr36 Cr74 CrSign in for TTM
Interest4 Cr5 Cr6 Cr5 Cr10 Cr7 Cr8 Cr12 CrSign in for TTM
Depreciation9 Cr13 Cr17 Cr17 Cr19 Cr26 Cr29 Cr33 CrSign in for TTM
Profit before tax182 Cr129 Cr104 Cr54 Cr106 Cr117 Cr126 Cr190 CrSign in for TTM
Tax %30.4%26.1%29.0%57.3%27.7%30.2%28.2%28.9%Sign in for TTM
Net profit127 Cr95 Cr74 Cr23 Cr77 Cr82 Cr90 Cr135 CrSign in for TTM
EPS (₹)₹11.99₹9.43₹6.64₹1.46₹6.83₹7.23₹8.02₹12.23Sign in for TTM
Dividend payout %———23.0%7.1%6.6%6.0%8.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr11 Cr11 Cr
Reserves636 Cr725 Cr798 Cr808 Cr873 Cr957 Cr1,040 Cr1,182 Cr
Borrowings97 Cr104 Cr98 Cr105 Cr98 Cr88 Cr71 Cr3 Cr
Other liabilities148 Cr175 Cr151 Cr157 Cr141 Cr123 Cr138 Cr258 Cr
Total liabilities905 Cr1,029 Cr1,077 Cr1,109 Cr1,157 Cr1,214 Cr1,301 Cr1,492 Cr
Fixed assets (net)135 Cr233 Cr225 Cr273 Cr370 Cr362 Cr397 Cr451 Cr
CWIP47 Cr0 Cr2 Cr22 Cr3 Cr8 Cr21 Cr6 Cr
Investments0.72 Cr0.72 Cr0.70 Cr3 Cr8 Cr5 Cr5 Cr6 Cr
Loans & advances0.32 Cr0.17 Cr0.16 Cr0.13 Cr0.10 Cr0.07 Cr0.04 Cr0.04 Cr
Inventories77 Cr74 Cr99 Cr124 Cr103 Cr118 Cr126 Cr151 Cr
Trade receivables461 Cr548 Cr464 Cr393 Cr385 Cr404 Cr438 Cr517 Cr
Cash & bank15 Cr15 Cr13 Cr22 Cr25 Cr23 Cr24 Cr35 Cr
Other assets169 Cr158 Cr273 Cr272 Cr262 Cr294 Cr290 Cr327 Cr
Total assets905 Cr1,029 Cr1,077 Cr1,109 Cr1,157 Cr1,214 Cr1,301 Cr1,492 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———135 Cr34 Cr152 Cr106 Cr139 Cr
Cash from investing———-93 Cr-8 Cr-133 Cr-75 Cr-38 Cr
Cash from financing———-24 Cr-25 Cr-21 Cr-30 Cr-89 Cr
Net cash flow———19 Cr3 Cr-1 Cr0.23 Cr11 Cr
Free cash flow (OCF − Capex)———135 Cr-59 Cr124 Cr30 Cr82 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %24.6%15.7%11.8%6.2%11.5%11.3%11.5%16.3%
ROE %19.0%13.3%9.4%2.7%7.7%7.5%7.7%10.5%
Debtor days187290292191187192197203
Inventory days130105139117114127123142
Days payable1321341048795667098
Cash conversion cycle184262327221205253250247
Debt / equity0.000.000.000.000.110.090.070.0025
Current ratio3.353.333.763.333.615.084.774.02
Net debt / EBITDA0.000.000.000.000.620.430.37-0.20

Compare with peers

Loading peers…